Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism

Genes & Immunity volume 3, pages 299–301 (2002)Cite this article

Abstract

An association study and a linkage analysis were carried out in parallel in order to investigate the association of the inducible nitric oxide synthase (NOS2) gene promoter polymorphism with rheumatoid arthritis (RA) predisposition and/or outcome including a −954G-C mutation, a di-allelic (TAAA)n marker and the highly polymorphic (CCTTT). The −954G-C point mutation occurred non-polymorphic and the di-allelic (TAAA)n marker was not associated with RA predisposition. The (CCTTT)nlocus showed a trend for RA association in the case-control study, however, stratification data by Class II status did not yield significant effect and overall, the family study showed no significant association nor linkage for any of the markers under study using TDT and non-parametric linkage respectively. Finally, no influence was detected regarding any of the clinical parameters tested. After evaluating for the first time the influence of NOS2 promoter polymorphism in RA, it seems to have no major effect on disease susceptibility and/or outcome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Weinberg JB . Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review Mol Med 1998 4: 557–591

    Article  CAS  Google Scholar 

  2. Stefanovic-Racic M, Stadler J, Evans CH . Nitric oxide and arthritis Arthritis Rheum 1993 36: 1036–1044

    Article  CAS  Google Scholar 

  3. Clancy RM, Amin AR, Abramson SB . The role of nitric oxide in inflammation and immunity Arthritis Rheum 1998 41: 1141–1151

    Article  CAS  Google Scholar 

  4. St Clair EW, Wilkinson WE, Lang T et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis J Exp Med 1996 184: 1173–1178

    Article  CAS  Google Scholar 

  5. van’t Hof RJ, Hocking L, Wright PK, Ralston SH . Nitric oxide is a mediator of apoptosis in the rheumatoid joint Rheumatology 2000 39: 1004–1008

    Article  Google Scholar 

  6. Kolb H, Kolb-Bachofen V . Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998 19: 556–561

    Article  CAS  Google Scholar 

  7. Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG . Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria Lancet 1998 351: 265–266

    Article  CAS  Google Scholar 

  8. Bellamy R, Hill AV . A bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric-oxide synthase gene Clin Genet 1997 52: 192–193

    Article  CAS  Google Scholar 

  9. Xu W, Liu L, Emson PC, Harrington CR, Charles IG . Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene Gene 1997 204: 165–170

    Article  CAS  Google Scholar 

  10. Warpeha KM, Xu W, Liu L et al. Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy FASEB 1999 13: 1825–1832

    Article  CAS  Google Scholar 

  11. Pascual M, Nieto A, Lopez-Nevot MA et al. Rheumatoid arthritis in southern Spain: towards a unifying role of the class II region in disease predisposition Arthritis Rheum 2001 44: 307–314

    Article  CAS  Google Scholar 

  12. Martin J, Calzada JE, Nieto A . Inducible nitric oxide synthase (NOS2) gene polymorphism and parasitic disease Lancet 1999 353: 72

    Article  CAS  Google Scholar 

  13. Johannesen J, Pociot F, Kristiansen OP, Karlsen AE, Nerup J . DIEGG and DSGD. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population Genes Immun 2000 1: 362–366

    Article  CAS  Google Scholar 

  14. Glenn CL, Wang WY, Morris BJ . Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives Hypertension 1999 33: 927–932

    Article  CAS  Google Scholar 

  15. Xu W, Humphries S, Tomita M et al. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease Nitric Oxide 2000 4: 379–383

    Article  CAS  Google Scholar 

  16. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis Arthritis Rheum 2000 43: 1366–1370

    Article  CAS  Google Scholar 

  17. Johannesen J, Tarnow L, Parving HH, Nerup J, Pociot F . CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients Diabetes Care 2000 23: 560–562

    Article  CAS  Google Scholar 

  18. Wei XQ, Charles IG, Smith A et al. Altered immune responses in mice lacking inducible nitric oxide synthase Nature 1995 375: 408–411

    Article  CAS  Google Scholar 

  19. Konno S, Hizawa N, Yamaguchi E, Jinushi E, Nishimura M . (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy J Allergy Clin Immunol 2001 108: 810–814

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Parasitologia y Biomedicina “López-Neyra”, CSIC, Granada, Spain

    M Pascual & J Martín

  2. Hospital Virgen de las Nieves, Granada, Spain

    M A López-Nevot & R Cáliz

  3. Department of Immunohematology and Blood Transfusion, L.U.M.C., Leiden, The Netherlands

    B P C Koeleman

  4. Hospital Universitario La Paz, Universidad Autónoma, Madrid, Spain

    A Balsa & D Pascual-Salcedo

Authors
  1. M Pascual
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M A López-Nevot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Cáliz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B P C Koeleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Balsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Pascual-Salcedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Martín
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Martín.

Additional information

This work was supported by grant SAF00-213 from Plan Nacional de I+D (CICYT).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pascual, M., López-Nevot, M., Cáliz, R. et al. Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism. Genes Immun 3, 299–301 (2002). https://doi.org/10.1038/sj.gene.6363856

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363856

Keywords

This article is cited by

Search

Advanced search

Quick links